Tannins from Hamamelis virginiana bark extract: Characterization and improvement of the antiviral efficacy against influenza a virus and human papillomavirus

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Theisen, Linda L ^a   Erdelmeier, Clemens A J ^b   Spoden, Gilles A ^c   Boukhallouk, Fatima ^c   Sausy, Aurélie ^a   Florin, Luise ^c   Muller, Claude P ^a  

^a LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIGALLOCATECHIN GALLATE; GALLIC ACID; HAMAMELIS VIRGINIANA EXTRACT; HAMAMELITANNIN; PLANT EXTRACT; PSEUDOTANNIN DERIVATIVE; SIALIDASE; TANNIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; BARK; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVITY; HAMAMELIS; HEMAGGLUTINATION; HUMAN PAPILLOMAVIRUS TYPE 16; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H7N9; KERATINOCYTE; LIFE CYCLE; MDCK CELL LINE; MOLECULAR WEIGHT; NONHUMAN; RECEPTOR BINDING; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; DOGS; HAMAMELIS; HUMAN PAPILLOMAVIRUS 16; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MADIN DARBY CANINE KIDNEY CELLS; PAPILLOMAVIRUS INFECTIONS; PLANT BARK; PLANT EXTRACTS; TANNINS;

EID: 84900442450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088062     Document Type: Article

References (87)

1. World Health Organization (2009) Fact sheet influenza (seasonal). Available: http://www.who.int/mediacentre/factsheets/fs211/en/index.html. Accessed 14 February 2013.
2. Centers for Disease Control and Prevention (2012) Update: Influenza Activity - United States, 2011-12 Season and Composition of the 2012-13 Influenza Vaccine. MMWR Morb Mortal Wkly Rep 61: 414-420.
3. Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, et al. (2009) Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med 361: 2296-2297. doi:10.1056/NEJMc0910060.
4. Gaur AH, Bagga B, Barman S, Hayden R, Lamptey A, et al. (2010) Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med 362: 88-89. doi:10.1056/NEJMc0910893.
5. Van der Vries E, Stelma FF, Boucher CAB (2010) Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. N Engl J Med 363: 1381-1382. doi:10.1056/NEJMc1003749.
6. Lackenby A, Moran Gilad J, Pebody R, Miah S, Calatayud L, et al. (2011) Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Eurosurveillance 16: 1-6.
7. Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, et al. (2011) Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med 365: 2541-2542. doi:10.1056/NEJMc1111078.
8. Manhart LE, Koutsky LA (2002) Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 29: 725-735. (Pubitemid 35266418)
9. Chelimo C, Wouldes TA, Cameron LD, Elwood JM (2013) Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Infect 66: 207-217. doi:10.1016/j.jinf.2012.10.024.
10. Repp KK, Nielson CM, Fu R, Schafer S, Lazcano-Ponce E, et al. (2012) Male human papillomavirus prevalence and association with condom use in Brazil, Mexico, and the United States. J Infect Dis 205: 1287-1293. doi:10.1093/infdis/ jis181.
11. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, et al. (2006) Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 354: 2645-2654. doi:10.1056/NEJMoa053284.
12. Nielson CM, Harris RB, Nyitray AG, Dunne EF, Stone KM, et al. (2010) Consistent condom use is associated with lower prevalence of human papillomavirus infection in men. J Infect Dis 202: 445-451. doi:10.1086/653708.
13. Buck CB, Thompson CD, Roberts JN, Müller M, Lowy DR, et al. (2006) Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog 2: e69. doi:10.1371/journal.ppat.0020069.
14. Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, et al. (2007) Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 13: 857-861. doi:10.1038/nm1598. (Pubitemid 47038188)
15. Selinka HC, Florin L, Patel HD, Freitag K, Schmidtke M, et al. (2007) Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol 81: 10970-10980. doi:10.1128/JVI.00998-07. (Pubitemid 47536071)
16. Buck CB, Day PM, Thompson CD, Lubkowski J, Lu W, et al. (2006) Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A 103: 1516-1521. doi:10.1073/pnas.0508033103. (Pubitemid 43191197)
17. Spoden GA, Besold K, Krauter S, Plachter B, Hanik N, et al. (2012) Polyethylenimine is a strong inhibitor of human papillomavirus and cytomegalovirus infection. Antimicrob Agents Chemother 56: 75-82. doi:10.1128/AAC.05147-11.
18. Mi X, Chai W, Zheng H, Zuo YG, Li J (2011) A randomized clinical comparative study of cryotherapy plus photodynamic therapy vs. cryotherapy in the treatment of multiple condylomata acuminata. Photodermatol Photoimmunol Photomed 27: 176-180. doi:10.1111/j.1600-0781.2011.00592.x.
19. Mistrangelo M, Cornaglia S, Pizzio M, Rimonda R, Gavello G, et al. (2010) Immunostimulation to reduce recurrence after surgery for anal condyloma acuminata: a prospective randomized controlled trial. Colorectal Dis 12: 799-803. doi:10.1111/j.1463-1318.2009.01960.x.
20. Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12: 564-582.
21. Wagner H (1999) Pharmazeutische Biologie Band 2; Arzneidrogen und ihre Inhaltsstoffe. Stuttgart: Wissenschaftliche Verlagsgesellschaft Stuttgart.
22. Sarni-Manchado P, Cheynier V, Moutounet M (1999) Interactions of grape seed tannins with salivary proteins. J Agric Food Chem 47: 42-47. (Pubitemid 29179620)
23. Hagerman AE (1992) Tannin-protein interactions. ACS Symp Ser 506: 236-247. doi:10.1021/bk-1992-0506.ch019.
24. Frazier RA, Deaville ER, Green RJ, Stringano E, Willoughby I, et al. (2010) Interactions of tea tannins and condensed tannins with proteins. J Pharm Biomed Anal 51: 490-495. doi:10.1016/j.jpba.2009.05.035.
25. Li M, Hagerman AE (2013) Interactions between plasma proteins and naturally occurring polyphenols. Curr Drug Metab 14: 432-445.
26. Haslam E (1996) Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J Nat Prod 59: 205-215. doi:10.1021/np960040+.
27. Jöbstl E, Howse JR, Fairclough JP, Williamson MP (2006) Noncovalent cross-linking of casein by epigallocatechin gallate characterized by single molecule force microscopy. J Agric Food Chem 54: 4077-4081. doi:10.1021/ jf053259f. (Pubitemid 44013305)
28. Williamson MP, McCormick TG, Nance CL, Shearer WT (2006) Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy. J Allergy Clin Immunol 118: 1369-1374. doi:10.1016/j.jaci.2006.08.016. (Pubitemid 44854123)
29. Haslam E (2007) Vegetable tannins - lessons of a phytochemical lifetime. Phytochemistry 68: 2713-2721. doi:10.1016/j.phytochem.2007.09.009.
30. Janecki A, Conrad A, Engels I, Frank U, Kolodziej H (2011) Evaluation of an aqueous-ethanolic extract from Pelargonium sidoides (EPs H 7630) for its activity against group A-streptococci adhesion to human HEp-2 epithelial cells. J Ethnopharmacol 133: 147-152. doi:10.1016/j.jep.2010.09.018.
31. Theisen LL, Muller CP (2012) EPs H 7630 (UmckaloaboH), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo. Antiviral Res 94: 147-156. doi:10.1016/j.antiviral.2012.03.006.
32. Hull Vance S, Tucci M, Benghuzzi H (2011) Evaluation of the antimicrobial efficacy of green tea extract (egcg) against streptococcus pyogenes in vitro - biomed 2011. Biomed Sci Instrum 47: 177-182.
33. Ikigai H, Nakae T, Hara Y, Shimamura T (1993) Bactericidal catechins damage the lipid bilayer. Biochim Biophys Acta 1147: 132-136. (Pubitemid 23104896)
34. Ciesek S, von Hahn T, Colpitts CC, Schang LM, Friesland M, et al. (2011) The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology 54: 1947-1955. doi:10.1002/hep.24610.
35. Nance CL, Shearer WT (2003) Is green tea good for HIV-1 infection? J Allergy Clin Immunol 112: 851-853. doi:10.1016/j.jaci.2003.08.048. (Pubitemid 37412050)
36. Song JM, Lee KH, Seong BL (2005) Antiviral effect of catechins in green tea on influenza virus. Antivir Res 68: 66-74. doi:S0166-3542(05)00144-0 [pii] 10.1016/j.antiviral.2005.06.010.
37. Carson RS, Frisch AW (1953) The inactivation of influenza viruses by tannic acid and related compounds. J Bacteriol 66: 572-575.
38. Liu G, Xiong S, Xiang YF, Guo CW, Ge F, et al. (2011) Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus. Arch Virol 156: 1359-1369. doi:10.1007/s00705-011-0989-9.
39. Deters A, Dauer A, Schnetz E, Fartasch M, Hensel A (2001) High molecular compounds (polysaccharides and proanthocyanidins) from Hamamelis virginiana bark: influence on human skin keratinocyte proliferation and differentiation and influence on irritated skin. Phytochemistry 58: 949-958. (Pubitemid 33086222)
40. Laux P, Oschmann R (1993) Die Zaubernuss - Hamamelis virginiana L. Zeitschrift für Phyther 14: 155-166.
41. Wolff HH, Kieser M (2007) Hamamelis in children with skin disorders and skin injuries: results of an observational study. Eur J Pediatr 166: 943-948. doi:10.1007/s00431-006-0363-1. (Pubitemid 47101350)
42. MacKay D (2001) Hemorrhoids and varicose veins: a review of treatment options. Altern Med Rev 6: 126-140.
43. Dauer A, Metzner P, Schimmer O (1998) Proanthocyanidins from the bark of Hamamelis virginiana exhibit antimutagenic properties against nitroaromatic compounds. Planta Med 64: 324-327. doi:10.1055/s-2006-957443. (Pubitemid 28234268)
44. Pereira da Silva A, Rocha R, Silva CM, Mira L, Duarte MF, et al. (2000) Antioxidants in medicinal plant extracts. A research study of the antioxidant capacity of Crataegus, Hamamelis and Hydrastis. Phytother Res 14: 612-616.
45. Touriño S, Lizárraga D, Carreras A, Lorenzo S, Ugartondo V, et al. (2008) Highly galloylated tannin fractions from witch hazel (Hamamelis virginiana) bark: electron transfer capacity, in vitro antioxidant activity, and effects on skinrelated cells. Chem Res Toxicol 21: 696-704. doi:10.1021/tx700425n. (Pubitemid 351498045)
46. European Medicines Agency (2009) Assessment report on Hamamelis virginiana L., cortex, Hamamelis virginiana L. folium, Hamamelis virginiana L., folium et cortex aut ramunculus destillatum. EMA/HMPC/1.
47. Erdelmeier CA, Cinatl J, Rabenau H, Doerr HW, Biber A, et al. (1996) Antiviral and antiphlogistic activities of Hamamelis virginiana bark. Planta Med 62: 241-245. doi:10.1055/s-2006-957868. (Pubitemid 26201422)
48. Dauer A, Rimpler H, Hensel A (2003) Polymeric proanthocyanidins from the bark of Hamamelis virginiana. Planta Med 69: 89-91. doi:10.1055/s-2003-37022. (Pubitemid 36228469)
49. González MJ, Torres JL, Medina I (2010) Impact of thermal processing on the activity of gallotannins and condensed tannins from Hamamelis virginiana used as functional ingredients in seafood. J Agric Food Chem 58: 4274-4283. doi:10.1021/jf904032y.
50. Sánchez-Tena S, Fernández-Cachón ML, Carreras A, Mateos-Martín ML, Costoya N, et al. (2012) Hamamelitannin from witch hazel (Hamamelis virginiana) displays specific cytotoxic activity against colon cancer cells. J Nat Prod 75: 26-33. doi:10.1021/np200426k.
51. Vennat B, Pourrat H, Pouget MP, Gross D, Pourrat A (1988) Tannins from Hamamelis virginiana: identification of proanthocyanidins and hamamelitannin quantification in leaf, bark, and stem extracts. Planta Med 54: 454-457. doi:10.1055/s-2006-962499.
52. Wang H, Provan GJ, Helliwell K (2003) Determination of hamamelitannin, catechins and gallic acid in witch hazel bark, twig and leaf by HPLC. J Pharm Biomed Anal 33: 539-544. doi:10.1016/S0731-7085(03)00303-0. (Pubitemid 37412600)
53. Takeda M, Ohno S, Seki F, Nakatsu Y, Tahara M, et al. (2005) Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol 79: 14346-14354. doi:10.1128/JVI.79. 22.14346-14354.2005. (Pubitemid 41552732)
54. Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, et al. (2001) Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol 75: 4399-4401. doi:10.1128/JVI.75.9.4399-4401.2001. (Pubitemid 32410152)
55. Kittel C, Sereinig S, Ferko B, Stasakova J, Romanova J, et al. (2004) Rescue of influenza virus expressing GFP from the NS1 reading frame. Virology 324: 67-73. doi:10.1016/j.virol.2004.03.035 S0042682204002053 [pii].
56. Buck CB, Pastrana DV, Lowy DR, Schiller JT (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol 78: 751-757. doi:10.1128/JVI.78.2. 751. (Pubitemid 38067597)
57. Schneider MA, Spoden GA, Florin L, Lambert C (2011) Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol 13: 32-46. doi:10.1111/j.1462-5822.2010.01515.x.
58. Ainsworth EA, Gillespie KM (2007) Estimation of total phenolic content and other oxidation substrates in plant tissues using Folin-Ciocalteu reagent. Nat Protoc 2: 875-877. doi:10.1038/nprot.2007.102. (Pubitemid 46745587)
59. European Directorate for the Quality of Medicines & Healthcare (2008) Bestimmung des Gerbstoffgehalts pflanzlicher Drogen. European Pharmacopoeia 6.0. p.328.
60. Bate-Smith E (1975) Phytochemistry of proanthocyanidins. Phytochemistry 14: 1107-1113.
61. Ehrhardt C, Hrincius ER, Korte V, Mazur I, Droebner K, et al. (2007) A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance. Antiviral Res 76: 38-47. doi:10.1016/j.antiviral.2007.05.002. (Pubitemid 47176692)
62. Knappe M, Bodevin S, Selinka HC, Spillmann D, Streeck RE, et al. (2007) Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate. J Biol Chem 282: 27913-27922. doi:10.1074/jbc.M705127200. (Pubitemid 47529517)
63. Spoden G, Freitag K, Husmann M, Boller K, Sapp M, et al. (2008) Clathrinand caveolin-independent entry of human papillomavirus type 16-involvement of tetraspanin-enriched microdomains (TEMs). PLoS One 3: e3313. doi:10.1371/journal.pone.0003313.
64. Scheffer KD, Gawlitza A, Spoden GA, Zhang XA, Lambert C, et al. (2013) Tetraspanin CD151 Mediates Papillomavirus Type 16 Endocytosis. J Virol 87: 3435-3446. doi:10.1128/JVI.02906-12.
65. Sapp M, Kraus U, Volpers C, Snijders PJ, Walboomers JM, et al. (1994) Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein. J Gen Virol 75 (Pt 12: 3375-3383.
66. Ueda K, Kawabata R, Irie T, Nakai Y, Tohya Y, et al. (2013) Inactivation of pathogenic viruses by plant-derived tannins: strong effects of extracts from persimmon (Diospyros kaki) on a broad range of viruses. PLoS One 8: e55343. doi:10.1371/journal.pone.0055343.
67. Mantani N, Andoh T, Kawamata H, Terasawa K, Ochiai H (1999) Inhibitory effect of Ephedrae herba, an oriental traditional medicine, on the growth of influenza A/PR/8 virus in MDCK cells. Antiviral Res 44: 193-200. (Pubitemid 30017946)
68. Lin LT, Chen TY, Lin SC, Chung CY, Lin TC, et al. (2013) Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol 13: 187. doi:10.1186/1471-2180-13- 187.
69. Hamilton BS, Whittaker GR, Daniel S (2012) Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion. Viruses 4: 1144-1168. doi:10.3390/v4071144.
70. Seto JT, Rott R (1966) Functional significance of sialidose during influenza virus multiplication. Virology 30: 731-737.
71. Betts JW, Kelly SM, Haswell SJ (2011) Antibacterial effects of theaflavin and synergy with epicatechin against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia. Int J Antimicrob Agents 38: 421-425. doi:10.1016/j.ijantimicag.2011.07.006.
72. Sasaki H, Matsumoto M, Tanaka T, Maeda M, Nakai M, et al. (2004) Antibacterial activity of polyphenol components in oolong tea extract against Streptococcus mutans. Caries Res 38: 2-8. doi:10.1159/000073913. (Pubitemid 38064885)
73. Takechi M, Tanaka Y, Takehara M, Nonaka G, Nishioka I (1985) Structure and antiherpetic activity among the tannins. Phytochemistry 24: 2245-2250.
74. Gescher K, Hensel A, Hafezi W, Derksen A, Kuhn J (2011) Oligomeric proanthocyanidins from Rumex acetosa L. inhibit the attachment of herpes simplex virus type-1. Antivir Res 89: 9-18. doi:S0166-3542(10)00770-9 [pii] 10.1016/j.antiviral.2010.10.007.
75. Nakayama M, Suzuki K, Toda M, Okubo S, Hara Y, et al. (1993) Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res 21: 289-299. (Pubitemid 23231550)
76. Steinmann J, Buer J, Pietschmann T, Steinmann E (2012) Anti-infective properties of Epigallocatechin-3-gallate (EGCG), a component of Green Tea. Br J Pharmacol. doi:10.1111/bph.12009.
77. Haidari M, Ali M, Ward Casscells S 3rd, Madjid M (2009) Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir. Phytomedicine 16: 1127-1136. doi:S0944-7113(09)00165-2 [pii] 10.1016/j.phymed.2009.06.002.
78. Imanishi N, Tuji Y, Katada Y, Maruhashi M, Konosu S, et al. (2002) Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Microbiol Immunol 46: 491-494. (Pubitemid 34831213)
79. Hashimoto T, Kumazawa S, Nanjo F, Hara Y, Nakayama T (1999) Interaction of tea catechins with lipid bilayers investigated with liposome systems. Biosci Biotechnol Biochem 63: 2252-2255. (Pubitemid 129549060)
80. Kratz JM, Andrighetti-Fröhner CR, Kolling DJ, Leal PC, Cirne-Santos CC, et al. (2008) Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate. Mem Inst Oswaldo Cruz 103: 437-442.
81. Lin LT, Chen TY, Chung CY, Noyce RS, Grindley TB, et al. (2011) Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J Virol 85: 4386-4398. doi:10.1128/JVI.01492-10.
82. Cerqueira C, Liu Y, Kühling L, Chai W, Hafezi W, et al. (2013) Heparin increases the infectivity of Human Papillomavirus Type 16 independent of cell surface proteoglycans and induces L1 epitope exposure. Cell Microbiol 15: 1818-1836. doi:10.1111/cmi.12150.
83. Florin L, Sapp M, Spoden GA (2012) Host-cell factors involved in papillomavirus entry. Med Microbiol Immunol 201: 437-448. doi:10.1007/s00430- 012-0270-1.
84. Raff AB, Woodham AW, Raff LM, Skeate JG, Yan L, et al. (2013) The evolving field of human papillomavirus receptor research: a review of binding and entry. J Virol 87: 6062-6072. doi:10.1128/JVI.00330-13.
85. Ishii T, Ichikawa T, Minoda K, Kusaka K, Ito S, et al. (2011) Human serum albumin as an antioxidant in the oxidation of (2)-epigallocatechin gallate: participation of reversible covalent binding for interaction and stabilization. Biosci Biotechnol Biochem 75: 100-106. doi:10.1271/bbb.100600.
86. Minoda K, Ichikawa T, Katsumata T, Onobori K, Mori T, et al. (2010) Influence of the galloyl moiety in tea catechins on binding affinity for human serum albumin. J Nutr Sci Vitaminol (Tokyo) 56: 331-334.
87. Kimmel EM, Jerome M, Holderness J, Snyder D, Kemoli S, et al. (2011) Oligomeric procyanidins stimulate innate antiviral immunity in dengue virus infected human PBMCs. Antiviral Res 90: 80-86. doi:10.1016/j.antiviral.2011.02. 011.